Contact: Katie Gommel
American Association for Justice
AAJ Press Room
Washington, DC—Establishing a reporting requirement that creates transparency of payments from drug and device manufacturers to doctors and hospitals will increase patient safety by reducing conflicts of interest, according to comments submitted today by the American Association for Justice (AAJ) to the Centers for Medicare and Medicaid Services (CMS).
Doctors may knowingly or unknowingly prescribe a drug or recommend a device based on a monetary relationship with a manufacturer, which can result in patients not receiving the best drug or device for their needs.
“We need to eliminate patients’ unnecessary exposure to potentially dangerous drugs and devices,” said AAJ President Gary M. Paul. “Transparency will allow patients to determine whether their physicians have any conflicts of interest and empower them to make an informed decision regarding the drugs or devices they are prescribed.”
With the growing number of drugs and devices manufactured outside the United States, AAJ supports including the reporting of foreign manufacturers’ conflicts of interests with clients based in the United States.
AAJ’s full submitted comments can be found here.